Atai Beckley, Inc. (DELISTED) (ATAI:DL)
7.35
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
Atai Beckley Cash from Operations (TTM) : -128.93M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -128.93M |
| March 31, 2026 | -109.14M |
| December 31, 2025 | -105.89M |
| September 30, 2025 | -77.84M |
| June 30, 2025 | -69.32M |
| March 31, 2025 | -76.59M |
| September 30, 2024 | -79.85M |
| June 30, 2024 | -78.28M |
| March 31, 2024 | -85.14M |
| Date | Value |
|---|---|
| December 31, 2023 | -83.67M |
| September 30, 2023 | -94.28M |
| June 30, 2023 | -100.69M |
| March 31, 2023 | -98.52M |
| December 31, 2022 | -101.39M |
| September 30, 2022 | -88.80M |
| June 30, 2022 | -91.27M |
| March 31, 2022 | -68.62M |
| December 31, 2021 | -61.16M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Eli Lilly & Co. | 28.08B |
| GH Research Plc | -52.32M |
| Johnson & Johnson | 27.61B |
| Merck & Co., Inc. | 19.97B |
| Definium Therapeutics, Inc. | -166.74M |